Asterarcys quadricellulare (Chlorophyceae) protects H9c2 cardiomyoblasts from H2O2-induced oxidative stress von Saadaoui, Imen, Bounnit, Touria, Mraiche, Fatima, Joseph, Jensa M., Cherif, Maroua, Al-Jabri, Hareb

Volltext

Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway von Achkar, Iman W, Abdulrahman, Nabeel, Al-Sulaiti, Hend, Joseph, Jensa Mariam, Uddin, Shahab, Mraiche, Fatima

Volltext

Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression von Abdulrahman, Nabeel, Ibrahim, Meram, Joseph, Jensa Mariam, Elkoubatry, Hanan Mahmoud, Al-Shamasi, Al-Anood, Rayan, Menatallah, Gadeau, Alain Pierre, Ahmed, Rashid, Eldassouki, Hussein, Hasan, Anwarul, Mraiche, Fatima

Volltext

Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells von Abdulrahman, Nabeel, Siveen, Kodappully Sivaraman, Joseph, Jensa Mariam, Osman, Aisha, Yalcin, Huseyin C., Hasan, Anwarul, Uddin, Shahab, Mraiche, Fatima

Volltext

Nanotechnology - a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer von Gorachinov, Filip, Mraiche, Fatima, Moustafa, Diala Alhaj, Hishari, Ola, Ismail, Yomna, Joseph, Jensa, Crcarevska, Maja Simonoska, Dodov, Marija Glavas, Geskovski, Nikola, Goracinova, Katerina

Volltext

Asterarcys quadricellulare protects H9c2 cardiomyoblasts from H.sub.2O.sub.2-induced oxidative stress von Saadaoui, Imen, Bounnit, Touria, Mraiche, Fatima, Joseph, Jensa M, Cherif, Maroua, Al-Jabri, Hareb

Volltext

Asterarcys quadricellulare (Chlorophyceae) protects H9c2 cardiomyoblasts from H 2 O 2 -induced oxidative stress von Saadaoui, Imen, Bounnit, Touria, Mraiche, Fatima, Joseph, Jensa M, Cherif, Maroua, Al-Jabri, Hareb

Volltext

Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway von Achkar, Iman W, Abdulrahman, Nabeel, Al-Sulaiti, Hend, Joseph, Jensa Mariam, Uddin, Shahab, Mraiche, Fatima

Volltext

Tranexamic Acid Administration at Hospital Admission Decreases Transfusion Rates in Geriatric Hip Fracture Patients Undergoing Surgery von Moran, Jay, Kahan, Joseph B., Morris, Jensa, Joo, Peter Y., O’Connor, Mary I.

Volltext

Integrated Fragility Hip Fracture Program: A Model for High Quality Care von Morris, Jensa C, Moore, Anne, Kahan, Joseph, Shapiro, Marc, Li, Jinlei, Spadaccino, Brooke, Baumgaertner, Michael, O'Connor, Mary I

Volltext

Expanded use of tranexamic acid is safe and decreases transfusion rates in patients with geriatric hip fractures von Kahan, Joseph B., Morris, Jensa, Li, Don, Moran, Jay, O’Connor, Mary I.

Volltext